High-level beta-globin expression and preferred intragenic integration after lentiviral transduction of human cord blood stem cells |
| |
| Authors: | Imren Suzan Fabry Mary E Westerman Karen A Pawliuk Robert Tang Patrick Rosten Patricia M Nagel Ronald L Leboulch Philippe Eaves Connie J Humphries R Keith |
| |
| Affiliation: | Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. |
| |
| Abstract: | Transplantation of genetically corrected autologous hematopoietic stem cells is an attractive approach for the cure of sickle-cell disease and beta-thalassemia. Here, we infected human cord blood cells with a self-inactivating lentiviral vector encoding an anti-sickling betaA-T87Q-globin transgene and analyzed the transduced progeny produced over a 6-month period after transplantation of the infected cells directly into sublethally irradiated NOD/LtSz-scid/scid mice. Approximately half of the human erythroid and myeloid progenitors regenerated in the mice containing the transgene, and erythroid cells derived in vitro from these in vivo-regenerated cells produced high levels of betaA-T87Q-globin protein. Linker-mediated PCR analysis identified multiple transgene-positive clones in all mice analyzed with 2.1 +/- 0.1 integrated proviral copies per cell. Genomic sequencing of vector-containing fragments showed that 86% of the proviral inserts had occurred within genes, including several genes implicated in human leukemia. These findings indicate effective transduction of very primitive human cord blood cells with a candidate therapeutic lentiviral vector resulting in the long-term and robust, erythroid-specific production of therapeutically relevant levels of beta-globin protein. However, the frequency of proviral integration within genes that regulate hematopoiesis points to a need for additional safety modifications. |
| |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ |
|
